Gregory Reaman
Impact in
-
- Childhood Cancer Survivors' Quality of Life
- Genetics top 10%
- Glioma Diagnosis and Treatment
Papers in
-
- Acute Lymphoblastic Leukemia research 9
-
- Childhood Cancer Survivors' Quality of Life 5
- Ethics and Legal Issues in Pediatric Healthcare 2
- Co-authors
- Franca Fossati‐Bellani (1 shared paper)Odile Oberlin (1 shared paper)Leslie L. Robison (1 shared paper)Elaine Morgan (1 shared paper)Frederick B. Ruymann (1 shared paper)Anna T. Meadows (1 shared paper)Lisa Diller (1 shared paper)Ravi Bhatia (1 shared paper)
- Journals
- Blood (5 papers)Journal of Immunotherapy (2 papers)Cancer (1 paper)Journal of Clinical Oncology (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesSwitzerlandAustralia
In The Last Decade
Gregory Reaman
18 papers receiving 886 citations
Peers
Comparison fields: 5 of 76
- Pediatrics, Perinatology and Child Health 289
- Genetics 148
- Pathology and Forensic Medicine 201
- Hematology 111
- Public Health, Environmental and Occupational Health 288
Countries citing papers authored by Gregory Reaman
This map shows the geographic impact of Gregory Reaman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Reaman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Reaman more than expected).
Fields of papers citing papers by Gregory Reaman
This network shows the impact of papers produced by Gregory Reaman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Reaman. The network helps show where Gregory Reaman may publish in the future.
Co-authors
The 25 scholars most cited alongside Gregory Reaman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 417 | |
| 2 | 1992 | 100 | |
| 3 | 2011 | 94 | |
| 4 | 1989 | 65 | |
| 5 | 1989 | 59 | |
| 6 | 2005 | 54 | |
| 7 | A phase I/II dose escalation and activity study of intravenous injections of OCaP1 for subjects with refractory osteosarcoma metastatic to lung. | 2001 | 30 |
| 8 | 1999 | 20 | |
| 9 | 1991 | 15 | |
| 10 | Clinical features and treatment outcome of children with biphenotypic CD2+ CD19+ acute lymphoblastic leukemia: a Children's Cancer Group study. | 1997 | 15 |
| 11 | 2005 | 14 | |
| 12 | 2008 | 13 | |
| 13 | 2014 | 8 | |
| 14 | 2015 | 7 | |
| 15 | 1997 | 4 | |
| 16 | 2007 | 3 | |
| 17 | 2020 | 2 | |
| 18 | 1997 | 1 |
About Gregory Reaman
Gregory Reaman is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health, Pathology and Forensic Medicine, Molecular Biology and Neurology, having authored 18 papers that have together received 921 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (9 papers), Childhood Cancer Survivors' Quality of Life (5 papers), Neuroblastoma Research and Treatments (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Ethics and Legal Issues in Pediatric Healthcare (2 papers), Acute Myeloid Leukemia Research (2 papers), Renal and related cancers (2 papers) and Virus-based gene therapy research (2 papers). The work is most often cited by research in Pediatrics, Perinatology and Child Health (289 citations), Genetics (148 citations), Pathology and Forensic Medicine (201 citations), Hematology (111 citations) and Public Health, Environmental and Occupational Health (288 citations). Gregory Reaman has collaborated with scholars based in United States, Switzerland and Australia. Frequent co-authors include Franca Fossati‐Bellani, Odile Oberlin, Leslie L. Robison, Elaine Morgan, Frederick B. Ruymann, Anna T. Meadows, Lisa Diller, Ravi Bhatia, Yutaka Yasui and Jillian M. Birch. Their work appears in journals such as Blood, Journal of Immunotherapy, Cancer, Journal of Clinical Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.